Elaine Mardis

Elaine Mardis is a pioneer in cancer genomics whose work on next-generation sequencing has enabled the identification of tumor-specific neoantigens for vaccine development. Her laboratory developed key computational pipelines for somatic variant detection and neoantigen prediction from tumor sequencing data. She has applied these tools in clinical settings to identify actionable neoantigens in pediatric and adult cancers. Her contributions have made personalized neoantigen vaccine development feasible at scale.